Abdurrahman Eren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdurrahman Eren has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ender Oner
Department of Cardiology University of Health Sciences Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital Istanbul Türkiye
1 shared publication - Engin Dondurmacı
Department of Cardiology, Gaziantep City Hospital, Gaziantep, Turkey
1 shared publication - Esra Polat
Department of Cardiology, Gaziantep City Hospital, Türkiye
1 shared publication - Hande Uysal
Department of Cardiology University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital Istanbul Turkey
1 shared publication - Hüseyin Karakurt
Department of Cardiology University of Health Sciences Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital Istanbul Türkiye
1 shared publication - Kadir Sadıkoğlu
Department of Cardiology University of Health Sciences Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital Istanbul Türkiye
1 shared publication
Latest Publications
- 27 October 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Conventional Atrioventricular Nodal Reentrant Tachycardia Ablation: 16‐Year Acute Outcomes and Pacemaker Requirement
Background: This study characterized the acute success, causes of failure, and index‐hospitalization permanent pacemaker (PPM) rate of conventional (fluoroscopy‐guided, without 3D electroanatomic mapping [3D‐EAM]) AVNRT ablation over 16 years at a single center. Methods: Consecutive adult patients (≥18 years) who underwent conventional ablation for AVNRT between January 2010 and May 2026 were retrospectively evaluated. All procedures were performed by a senior operator or under the direct supervision of a senior operator. Acute success was defined as non‐inducibility of AVNRT under isoproterenol. The primary endpoints were index‐hospitalization PPM and acute success. Rates are presented with Wilson 95% confidence intervals (CIs). Results: Of 1169 SVT cases, 814 (69.6%) underwent AVNRT ablation (age 46.9 ± 13.0 years; 67.0% female). Acute success was 90.3% (735/814; 95% CI 88.07–92.14). Causes of failure ( n = 79): anatomic limitation 40 (50.6%), persistent inducibility 29 (36.7%), AV conduction disturbance 8 (10.1%), patient intolerance 1, atrial fibrillation 1. Anatomic limitation denotes ablation deliberately terminated to protect AV conduction rather than technical failure. High‐grade AV block developed in 8 patients (0.98%); it resolved spontaneously in 5, and a PPM was implanted during the index hospitalization in 3 (0.37%; 95% CI 0.13–1.08). In the three PPM patients, ventricular pacing remained 100% at follow‐up. Acute success showed no significant univariable association with age or sex. Conclusions: Conventional AVNRT ablation can be performed at an experienced center with high success (90.3%) and a low PPM rate (0.37%). While some AV block events resolved in the laboratory, those that persisted led to a PPM requirement, and AV conduction was not regained in these patients. These findings provide operator‐homogeneous real‐world reference data from a tertiary referral center in Türkiye.
- 27 October 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Conventional Atrioventricular Nodal Reentrant Tachycardia Ablation: 16‐Year Acute Outcomes and Pacemaker Requirement
Background: This study characterized the acute success, causes of failure, and index‐hospitalization permanent pacemaker (PPM) rate of conventional (fluoroscopy‐guided, without 3D electroanatomic mapping [3D‐EAM]) AVNRT ablation over 16 years at a single center. Methods: Consecutive adult patients (≥18 years) who underwent conventional ablation for AVNRT between January 2010 and May 2026 were retrospectively evaluated. All procedures were performed by a senior operator or under the direct supervision of a senior operator. Acute success was defined as non‐inducibility of AVNRT under isoproterenol. The primary endpoints were index‐hospitalization PPM and acute success. Rates are presented with Wilson 95% confidence intervals (CIs). Results: Of 1169 SVT cases, 814 (69.6%) underwent AVNRT ablation (age 46.9 ± 13.0 years; 67.0% female). Acute success was 90.3% (735/814; 95% CI 88.07–92.14). Causes of failure ( n = 79): anatomic limitation 40 (50.6%), persistent inducibility 29 (36.7%), AV conduction disturbance 8 (10.1%), patient intolerance 1, atrial fibrillation 1. Anatomic limitation denotes ablation deliberately terminated to protect AV conduction rather than technical failure. High‐grade AV block developed in 8 patients (0.98%); it resolved spontaneously in 5, and a PPM was implanted during the index hospitalization in 3 (0.37%; 95% CI 0.13–1.08). In the three PPM patients, ventricular pacing remained 100% at follow‐up. Acute success showed no significant univariable association with age or sex. Conclusions: Conventional AVNRT ablation can be performed at an experienced center with high success (90.3%) and a low PPM rate (0.37%). While some AV block events resolved in the laboratory, those that persisted led to a PPM requirement, and AV conduction was not regained in these patients. These findings provide operator‐homogeneous real‐world reference data from a tertiary referral center in Türkiye.
- 28 February 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
THE RELATIONSHIP BETWEEN EPISODE FREQUENCY AND FUNCTIONAL CAPACITY IN PATIENTS TREATED WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
Introduction: Left ventricular ejection fraction (EF) is an important parameter for determining the frequency of ventricular arrhythmia episodes in patients treated with implantable cardioverter defibrillators (ICD). However, the relationship between heart failure and ICD episode frequency is controversial. This study aimed to evaluate the relationship between ICD episode frequency and functional capacity in patients classified according to the New York Heart Association (NYHA). Methods: The frequency of ventricular arrhythmia episodes was examined in patients who had a ICD implanted between January 1998 and April 2004. Seventy consecutive patients were retrospectively reviewed. Class I-II, II, and II-III patients were grouped into Group A, and Class III patients were grouped into Group B. The patients' demographic data, echocardiography findings, EFs, NYHA clinical status, indications for ICD implantation, and ICD episodes were examined. Results: The mean follow-up period for patients was 3.08±1.31 years. Two patients were NYHA class I-II, 15 patients were NYHA class II, 41 patients were NYHA class II-III, and 12 patients were NYHA class III. A total of 791 appropriately treated episodes of sustained ventricular tachycardia or ventricular fibrillation were observed in 70 patients. When these episodes were analyzed according to NYHA group, the frequency of ventricular arrhythmia episodes was higher in the Group B patient group (8.36±21.18 vs 25.33±27.63, p=0.019). Conclusions: NYHA class III heart failure is an easily assessable clinical measure and an important risk factor for the need for ICD treatment of ventricular arrhythmias. The rate of benefit from ICD treatment is higher in patients in the NYHA class III group.
- 28 February 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
THE RELATIONSHIP BETWEEN EPISODE FREQUENCY AND FUNCTIONAL CAPACITY IN PATIENTS TREATED WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
Introduction: Left ventricular ejection fraction (EF) is an important parameter for determining the frequency of ventricular arrhythmia episodes in patients treated with implantable cardioverter defibrillators (ICD). However, the relationship between heart failure and ICD episode frequency is controversial. This study aimed to evaluate the relationship between ICD episode frequency and functional capacity in patients classified according to the New York Heart Association (NYHA). Methods: The frequency of ventricular arrhythmia episodes was examined in patients who had a ICD implanted between January 1998 and April 2004. Seventy consecutive patients were retrospectively reviewed. Class I-II, II, and II-III patients were grouped into Group A, and Class III patients were grouped into Group B. The patients' demographic data, echocardiography findings, EFs, NYHA clinical status, indications for ICD implantation, and ICD episodes were examined. Results: The mean follow-up period for patients was 3.08±1.31 years. Two patients were NYHA class I-II, 15 patients were NYHA class II, 41 patients were NYHA class II-III, and 12 patients were NYHA class III. A total of 791 appropriately treated episodes of sustained ventricular tachycardia or ventricular fibrillation were observed in 70 patients. When these episodes were analyzed according to NYHA group, the frequency of ventricular arrhythmia episodes was higher in the Group B patient group (8.36±21.18 vs 25.33±27.63, p=0.019). Conclusions: NYHA class III heart failure is an easily assessable clinical measure and an important risk factor for the need for ICD treatment of ventricular arrhythmias. The rate of benefit from ICD treatment is higher in patients in the NYHA class III group.